Rx News Connection: November 2023
In the medical arena, information changes quickly. What was irrelevant yesterday, may be paramount today. PharmCon News Connection series seeks to distill the most impactful news for health professionals from the vast sea of news that confronts us all, then bridge the gap between the immediacy of those critical items and the delay that occurs as that information is incorporated into more focused programming. Our team of skilled editors continually scans the emerging medical news to bring the most relevant pieces to the forefront and deliver them to you in a concise, practical manner. In this session, we investigate timely items, including: FDA Advisory Committee Recommendation on OTC Phenylephrine, Investigational Factor XI Inhibitor Compared with Rivaroxaban, Recommendations for Neonates and Infants in RSV Season, 2023-2024 Updated COVID-19 Vaccine, NIH Begins Human Trials for Novel Influenza Vaccine, and Medication Errors in Children on ADHD Medications.